These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 14978854

  • 21. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
    Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, Frison L, Halperin JL.
    Eur Heart J; 2006 Aug; 27(16):1947-53. PubMed ID: 16774980
    [Abstract] [Full Text] [Related]

  • 22. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.
    O'Brien CL, Gage BF.
    JAMA; 2005 Feb 09; 293(6):699-706. PubMed ID: 15701911
    [Abstract] [Full Text] [Related]

  • 23. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS, THRIVE Treatment Study Investigators.
    JAMA; 2005 Feb 09; 293(6):681-9. PubMed ID: 15701909
    [Abstract] [Full Text] [Related]

  • 24. New possibilities in anticoagulant management of atrial fibrillation.
    Waldo AL.
    Rev Cardiovasc Med; 2004 Feb 09; 5 Suppl 5():S30-8. PubMed ID: 15619613
    [Abstract] [Full Text] [Related]

  • 25. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
    Halperin JL.
    J Am Coll Cardiol; 2005 Jan 04; 45(1):1-9. PubMed ID: 15629364
    [Abstract] [Full Text] [Related]

  • 26. Ximelagatran: a new oral anticoagulant.
    Hrebickova L, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 Jan 04; 5(6):397-408. PubMed ID: 14633322
    [Abstract] [Full Text] [Related]

  • 27. Ximelagatran or warfarin in atrial fibrillation?
    Stöllberger C, Finsterer J.
    Lancet; 2004 Feb 28; 363(9410):734-5; author reply 736. PubMed ID: 15001336
    [No Abstract] [Full Text] [Related]

  • 28. Ximelagatran.
    Choudhury A, Goyal D, Lip GY.
    Drugs Today (Barc); 2006 Jan 28; 42(1):3-19. PubMed ID: 16511607
    [Abstract] [Full Text] [Related]

  • 29. Ximelagatran or warfarin in atrial fibrillation?
    Eikelboom J, Hankey G.
    Lancet; 2004 Feb 28; 363(9410):734; author reply 734, 736. PubMed ID: 15001334
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.
    Cleland JG, Shelton R, Nikitin N, Ford S, Frison L, Grind M.
    Eur J Heart Fail; 2007 Feb 28; 9(6-7):730-9. PubMed ID: 17360232
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ximelagatran or warfarin in atrial fibrillation?
    Epstein EF.
    Lancet; 2004 Feb 28; 363(9410):736; author reply 736. PubMed ID: 15001338
    [No Abstract] [Full Text] [Related]

  • 34. [Preventing cerebrovascular accidents during atrial fibrillation].
    Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A.
    Presse Med; 2005 Oct 22; 34(18):1315-24. PubMed ID: 16269996
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of hypertension on anticoagulated patients with atrial fibrillation.
    Lip GY, Frison L, Grind M, SPORTIF Invetigators.
    Eur Heart J; 2007 Mar 22; 28(6):752-9. PubMed ID: 17289744
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
    Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW, EXULT A Study Group.
    N Engl J Med; 2003 Oct 30; 349(18):1703-12. PubMed ID: 14585938
    [Abstract] [Full Text] [Related]

  • 39. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 40. Will this be the end of the anticoagulation clinic for patients with atrial fibrillation?
    Mitchell AR.
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct 11; 5(5):405-8. PubMed ID: 16248832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.